Ingrid Remy

Ingrid Remy is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biomolecular interactions through her innovative work in protein fragment complementation assays. With a total of 10 patents to her name, her research has paved the way for advancements in detecting biological and drug interactions.

Latest Patents

One of her latest patents focuses on protein fragment complementation assays for the detection of biological or drug interactions. This invention describes a strategy for designing and implementing assays to detect biomolecular interactions both in vivo and in vitro. The design and implementation of this strategy are illustrated through various enzymes, particularly highlighting murine dihydrofolate reductase (DHFR). The method involves coexpressing fusion peptides consisting of N- and C-terminal fragments of murine DHFR, which, when combined, restore enzyme activity. This innovative approach allows for the study of various molecular interactions, including protein-protein, protein-DNA, and protein-small molecule interactions.

Career Highlights

Ingrid Remy has worked with several companies, including Odyssey Thera Inc. and Odyssey Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in the field of biomolecular research.

Collaborations

Throughout her career, Ingrid has collaborated with notable colleagues such as Stephen William Watson Michnick and Joelle Nina Pelletier. These collaborations have further enriched her research and innovations in the field.

Conclusion

Ingrid Remy's contributions to the field of protein fragment complementation assays have significantly advanced the understanding of biomolecular interactions. Her innovative patents and collaborations highlight her role as a leading inventor in this important area of research.

This text is generated by artificial intelligence and may not be accurate.